Europe Elispot And Fluorospot Assay Market Size & Outlook

The elispot and fluorospot assay market in Europe is expected to reach a projected revenue of US$ 137.4 million by 2030. A compound annual growth rate of 6.3% is expected of Europe elispot and fluorospot assay market from 2024 to 2030.
Revenue, 2023 (US$M)
$89.5
Forecast, 2030 (US$M)
$137.4
CAGR, 2024 - 2030
6.3%
Report Coverage
Europe

Europe elispot and fluorospot assay market, 2018-2030 (US$M)

Europe

Europe elispot and fluorospot assay market highlights

  • The Europe elispot and fluorospot assay market generated a revenue of USD 89.5 million in 2023.
  • The market is expected to grow at a CAGR of 6.3% from 2024 to 2030.
  • In terms of segment, assay kits was the largest revenue generating product in 2023.
  • Assay Kits is the most lucrative product segment registering the fastest growth during the forecast period.


Europe data book summary

Market revenue in 2023USD 89.5 million
Market revenue in 2030USD 137.4 million
Growth rate6.3% (CAGR from 2023 to 2030)
Largest segmentAssay kits
Fastest growing segmentAssay Kits
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationAssay Kits
Key market players worldwideBecton Dickinson & Co, U-CyTech, Cellular Technology Limited ‰ÛÓ CTL, Mabtech, Abcam PLC, Lophius Biosciences, Bio-Connect, Oxford Immunotec, Bio-Techne Corp


Other key industry trends

  • In terms of revenue, Europe region accounted for 30.5% of the global elispot and fluorospot assay market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 115.2 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Elispot and Fluorospot Assay Market Scope

Elispot and fluorospot assay market segmentation & scope
Assay Kits
Analyzers
Ancillary Products
Application
Research Applications
Diagnostics Applications
End Use
Hospital and Clinical Labs
Academic and Research Institutes
Biopharmaceutical Company
Countries
U.S.
Canada
Mexico
UK
Germany
France
Italy
Spain
Sweden
Norway
Denmark
India
China
Japan
Australia
South Korea
Thailand
Brazil
Argentina
South Africa
Saudi Arabia
UAE
Kuwait

Elispot and Fluorospot Assay Market Companies

Name Profile # Employees HQ Website

Europe elispot and fluorospot assay market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to elispot and fluorospot assay market will help companies and investors design strategic landscapes.


Assay kits was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Europe elispot and fluorospot assay market based on assay kits covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Europe elispot and fluorospot assay market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe elispot and fluorospot assay market databook

  • Our clientele includes a mix of elispot and fluorospot assay market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe elispot and fluorospot assay market , including forecasts for subscribers. This continent databook contains high-level insights into Europe elispot and fluorospot assay market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe elispot and fluorospot assay market

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more